BioSpace News Archive

PDS Biotechnology Corporation announced the successful completion of a Type B meeting with the U.S. Food and Drug Administration for a combination therapy of PDS0101, PDS0301 and an FDA-approved immune checkpoint inhibitor for the treatment of recurrent/metastatic human papilloma virus -positive, ICI refractory head and neck cancer.

Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces the addition of Roger Sawhney, M.D. to its Board of Directors.

Cullinan Oncology, Inc. today announced that its President and Chief Executive Officer, Nadim Ahmed, will present at Cowen’s 43rd Annual Health Care Conference on March 6, 2023 at 11:10 AM EST.

Intercept Pharmaceuticals, Inc. today announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will participate in a fireside chat at Cowen’s 43rd Annual Health Care Conference, taking place in person on Tuesday, March 7, 2023.

Actinium Pharmaceuticals today announced that it will host a key opinion leader (KOL) webinar at 8 a.m. EST on Tuesday, February 28, 2023, to discuss the results from the recently completed pivotal Phase 3 SIERRA trial of Iomab-B, which were presented in a late-breaker presentation at the Transplantation & Cellular Therapy (TCT) tandem meetings on February 18, 2023.

Saranas® Inc., a medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications, announced the hiring of seasoned medtech executive, Mike MacKinnon, as Chief Executive Officer.

Revance Therapeutics, Inc. (RVNC), today announced that the company will participate in the 43rd Annual Cowen Healthcare Conference, taking place March 6-8, 2023, in Boston, Massachusetts.

Pear Therapeutics, Inc. today announced the Company will participate in the 43rd Annual Cowen Healthcare Conference being held March 6-8, 2023 in Boston.

Carterra Expands Best-in-Class Franchise With the Launch of the LSA XT High-Throughput SPR Biosensor at SLAS 2023.

Elpiscience Biopharmaceuticals, Inc. today announced that the first patient has been dosed in a Phase 1 clinical trial of ES014, a first-in-class anti-CD39xTGF-β bispecific antibody (bsAb).